| 2025-04-02 | +0.5 % |
|
| 2025-04-01 | +0.69 % |
- Salesforce (CRM) stock rose 0.69% due to investor optimism following nCino, Inc.'s announcement of a $100 million stock repurchase program, reflecting confidence in their long-term strategy and potential for generating shareholder value.
- Salesforce (CRM) stock experienced a slight increase of 0.69% following a period of midday trading where it initially dropped by 2.7% due to Jefferies Financial Group lowering its price target, amidst generally positive analyst ratings and institutional investor activity. The stock's rise can be attributed to ongoing investor confidence, as indicated by multiple buy ratings from analysts and the announcement of a dividend increase.
- Salesforce (CRM) stock rose by 0.69% due to its inclusion in a list of prominent artificial intelligence stocks that are garnering investor attention, as companies in this sector are anticipated to benefit significantly from advancements in AI technologies.
- Salesforce (CRM) stock rose by 0.69% due to strong earnings results reported by DocuSign, indicating positive market sentiment and investment shifts towards technology stocks.
- Salesforce (CRM) stock rose by 0.63% in light of the recent news that OpenAI, a competitor in the AI space, secured a significant $40 billion funding round, raising its valuation to $300 billion, which highlights investor interest and confidence in the tech industry overall.
The increase in Salesforce stock can be attributed to a broader positive momentum in the technology sector driven by substantial investments in artificial intelligence, as seen with OpenAI's fundraising success, which can elevate the entire market's sentiment toward tech companies, including Salesforce.
|
| 2025-03-31 | -0.6 % |
|
| 2025-03-28 | -2.82 % |
|
| 2025-03-27 | -1.13 % |
- Salesforce (CRM) stock declined by 1.13% due to overall market sentiment and possible pressure from disappointing quarterly earnings results, as seen in similar tech stocks like Globant, which reported lower-than-expected earnings.
- Salesforce (CRM) stock declined by 1.13% likely due to market reactions to recent financial results or industry trends, although the specific reasons for this decline were not detailed in the article.
- Salesforce (CRM) stock decreased by 1.13%, likely due to broader market reactions or investor concerns related to the competitiveness and integration of AI technologies in their business model, as highlighted in discussions about companies needing to adapt to AI advancements and protect their data.
- Salesforce's stock (CRM) fell 1.13% despite the announcement of an expanded strategic partnership with Deloitte focused on developing scalable AI solutions for enterprise digital marketing. The stock decline may be attributed to broader market reactions or investor sentiment regarding potential challenges in the adoption and integration of new technologies, despite the partnership's promising prospects.
- Salesforce, Inc. (NYSE: CRM) shares dropped 1.8% after several insiders, including CEO Brian Millham, sold a significant number of shares, indicating potential concerns about the company's future performance or direction.
|
| 2025-03-26 | -2.64 % |
|
| 2025-03-25 | +0.93 % |
|
| 2025-03-24 | +1.9 % |
|
| 2025-03-21 | +0.57 % |
- Salesforce (CRM) stock experienced a 0.57% increase, likely driven by growing investor interest in the metaverse, as companies like NVIDIA, Accenture, and Globant continue to gain attention for their roles in developing related technologies.
- Salesforce (CRM) stock increased by 0.57% due to positive market sentiment following a strong quarterly earnings report for DocuSign, indicating robust financial performance and attracting investor interest.
- Salesforce (CRM) stock rose 0.57% following a strong-buy upgrade from Stephens and positive price target adjustments from several analysts, reflecting heightened investor confidence in the company’s performance.
- Salesforce (CRM) stock increased by 0.57% last night, likely boosted by the positive market reaction to Ingram Micro's launch of its AI-powered Xvantage Integrations Hub, which enhances integration capabilities with Salesforce and signifies an ongoing trend of technological innovation and efficiency in the SaaS sector.
- Salesforce (CRM) stock increased by 0.57% last night, likely due to positive sentiment from institutional investor activities, including significant stake increases in related technology stocks such as Globant S.A., indicating confidence in the technology sector's performance.
|
| 2025-03-20 | -0.13 % |
- Salesforce (CRM) stock decreased by 0.13% due to changes in corporate practices surrounding diversity, equity, and inclusion (DEI) initiatives amid new SEC guidelines and broader political shifts that may impair investor confidence in ESG-related investments.
- Salesforce (CRM) stocks experienced a decrease of 0.13%, part of a broader decline where the stock was down 12.19% over the past month and 9.33% over the last year, as investor focus shifted toward AI stocks perceived as having greater potential for returns.
- Salesforce's stock (CRM) declined by 0.13% amid general market fluctuations in healthcare stocks, potentially indicating investor concerns or profit-taking in response to recent trading activity, despite the company's strong performance in Customer Relationship Management technologies.
- Salesforce (CRM) stock fell by 0.13% primarily due to broader market trends and investor sentiment, rather than specific news related to Salesforce itself, as indicated in the context of the recent merger activity in the pharmaceutical sector, which can reflect or impact wider market movements.
- Salesforce (CRM) stock decreased by 0.13% as it traded down $3.26 to $277.50, reflecting a broader trend of declines in manufacturing stocks, which may indicate investor concerns about economic performance in the sector.
|
| 2025-03-19 | +0.24 % |
- Salesforce, Inc. (CRM) stock saw a slight increase of 0.24% despite a price target reduction from Scotiabank, as a number of other brokerages issued positive outlooks and buy ratings, indicating continued investor interest and confidence in the company. The stock's upward movement can be attributed to the support from other analysts maintaining or upgrading their ratings despite the price target cut, as well as notable insider transactions that suggest confidence from company leadership in its future performance.
- Salesforce (CRM) stock increased by 0.24% likely due to positive sentiment regarding the competitive positioning and growth potential of the cloud sector, especially in light of Alphabet's significant acquisition of cybersecurity firm Wiz, which underscores the increasing focus on cybersecurity solutions in the cloud market.
- Salesforce (CRM) stock rose 0.24% despite a price target reduction by Scotiabank due to analysts' overall supportive ratings, indicating a potential upside and continued investor interest driven by positive market sentiment and hedge fund activity.
- Salesforce (CRM) stock saw a slight increase of 0.24% due to positive market sentiment surrounding its integration capabilities and promising quarterly earnings report from DocuSign, which reported better-than-expected earnings and revenue, boosting investor confidence.
- Salesforce (CRM) stock rose by 0.24% due to a broader investor interest in Metaverse stocks, where companies like Salesforce are recognized for contributing to emerging technologies related to virtual and augmented realities that attract new investments.
|
| 2025-03-18 | -0.72 % |
- The article details recent changes in institutional investments and stock performance of DocuSign (NASDAQ:DOCU), highlighting a boost in holdings by Independent Advisor Alliance and various brokerage ratings. Salesforce (CRM) stock declined by -0.72% due to broader market trends or specific concerns about the tech sector, as indicated by the context surrounding stock performance, although the article does not provide direct reasons for Salesforce's decline.
- Salesforce (CRM) stock was down 0.72% last night, potentially due to market trends influenced by competition and trends in the broader tech sector, specifically related to companies involved in blockchain technology.
- Salesforce (CRM) stock saw a decline of -0.72%, likely influenced by broader market trends, as analysts provided mixed reviews on related companies like DocuSign, indicating cautious sentiment in the tech sector.
- Salesforce (CRM) stock decreased by 0.72% amid fluctuating trading volumes and broader market movements within the Artificial Intelligence sector, which includes notable stocks like Super Micro Computer and ServiceNow. The possible reasons for the decline could be fluctuations in the tech market overall, investor sentiment, or competition within the AI space impacting CRM's perceived value.
- Salesforce (CRM) stock experienced a decline of 0.72%, which can be attributed to market corrections or investor sentiment, though specific reasons for the drop were not detailed in the provided article.
|
| 2025-03-17 | +0.48 % |
|
| 2025-03-14 | +2.82 % |
- Salesforce (CRM) stock increased by 2.82% due to positive developments in institutional investment, including significant acquisitions by various hedge funds and adjustments in analysts' ratings that suggest a potential for growth, despite recent earnings misses.
- Salesforce (CRM) stock rose 2.82% due to positive market sentiment and interest in its potential for growth, highlighted by discussions about the importance of prudent fundraising and exit strategies for startups, which reinforces the value of companies like Salesforce in the tech ecosystem.
- Salesforce, Inc. (NYSE:CRM) experienced a 2.82% increase in stock price, supported by a consensus rating of "Moderate Buy" from analysts and positive adjustments to price targets from several brokerages, reflecting confidence in the company's growth potential and performance.
- Salesforce (CRM) stock rose by 2.82% likely due to positive analyst ratings and optimistic price targets set by various equities researchers, indicating strong potential for future growth in the face of recent earnings reports.
- Salesforce (CRM) stock rose by 2.82% last night, likely due to its relatively low exposure to the ongoing tariff-related tensions and trade war, thereby positioning it as a potential beneficiary in the US software sector amid increasing domestic technology spending.
|
| 2025-03-13 | -4.51 % |
- Salesforce (CRM) stock fell by 4.51% due to disappointing quarterly results and guidance, leadership concerns over a CEO viewed as increasingly disconnected from the business, and uncertainties regarding AI-driven growth potential amid a backdrop of decelerating revenue.
- Salesforce (CRM) stock fell by 4.51%, likely due to a combination of selling activity by insiders, mixed ratings from research analysts, and broader market conditions affecting tech stocks.
- Salesforce (CRM) stock declined by 4.51% following market reactions to a combination of a softer-than-expected U.S. inflation report and the escalation of trade tensions, particularly the implementation of new tariffs by the U.S. government, which are raising concerns about potential impacts on the broader economy.
- The article discusses the performance of Globant S.A. (NYSE:GLOB) stock, which has received a mixed consensus rating from analysts, with a moderate buy recommendation despite a recent quarterly earnings miss that likely contributed to its stock decline.
Salesforce (CRM) stock's decline may be linked to broader market dynamics, investor sentiment, or specific concerns regarding the company's financial performance or guidance, but the article did not provide specific reasons for its drop.
- Salesforce (CRM) stock declined by 4.51% due to broader market concerns around tariff threats and their potential impact on the U.S. economy, along with negative sentiment following analysts' downgrades and lower price targets for several companies within the tech sector.
|
| 2025-03-12 | +2.72 % |
|
| 2025-03-11 | +1.52 % |
|
| 2025-03-10 | -3.53 % |
- The article discusses the performance of Ntt Data compared to its rivals in the custom computer programming services industry, noting its lower volatility and more favorable valuation despite having lower growth prospects according to analysts. However, it does not provide specific reasons for the decline in Salesforce (CRM) stock, which was down 3.53%. Possible general reasons for Salesforce's decline could include market reactions to earnings reports, macroeconomic factors, competitive pressures, or changes in analyst ratings, but these specifics are not detailed in the provided text.
- Salesforce's stock (CRM) fell by 3.53% following a drop in its trading value to $282.74, likely influenced by broader market trends impacting technology stocks and investor reactions to the stock's previous high valuation compared to its recent trading averages.
- Salesforce (CRM) stock saw a decline of 3.53% amidst increasing competitive pressure following ServiceNow's announcement of a significant acquisition of AI firm Moveworks, highlighting a growing trend of companies investing heavily in AI technology to enhance their operations, which may affect Salesforce's market position.
- Salesforce (CRM) stock decreased by 3.53% following ServiceNow's announcement of its $2.85 billion acquisition of AI firm Moveworks, signaling increased competitive pressure in the AI-enhanced software market.
|
| 2025-03-07 | -1.1 % |
|
| 2025-03-06 | -2.03 % |
|
| 2025-03-05 | +1.61 % |
|
| 2025-03-04 | -1.95 % |
|
| 2025-02-28 | +1 % |
|
| 2025-02-27 | -4.04 % |
- Salesforce (CRM) stock experienced a decline of 4.04% last night, likely influenced by broader market trends and investor sentiment reflecting concerns over recent insider selling and mixed ratings from analysts regarding company performance.
- Salesforce (CRM) stock fell by 4.04% due to a disappointing forecast regarding its AI initiative, "Agentforce," which is expected to contribute only modestly to revenue, compounded by broader market concerns about the sustainability of spending on AI following Nvidia's mixed earnings report.
- Salesforce (CRM) stock fell 4.04% due to disappointing revenue forecasts despite beating analysts' profit expectations in its latest quarter, contributing to a broader decline in market sentiment following a downturn in high-momentum AI stocks like Nvidia.
- Salesforce (CRM) stock experienced a decline of 4.04%, potentially due to market reactions to economic indicators, earnings reports, or competitive pressures in the CRM sector, though specific reasons weren't detailed in the article.
- Salesforce (CRM) stock fell by 4.04% due to mixed quarterly results and weak guidance despite growth in its AI business, which is expected to drive long-term gains.
|
| 2025-02-26 | +0.47 % |
- Salesforce (CRM) stock was up 0.47% due to increasing institutional investor interest and a general positive sentiment around its growth potential compared to its competitors in the custom computer programming services industry, despite analysts suggesting it has less favorable growth aspects.
- Salesforce (CRM) stock rose 0.47% last night, likely due to positive activity from institutional investors, analysts showing a mix of hold and buy ratings, and previous upgrades on target prices, which indicate a favorable outlook for the company's performance.
- Salesforce (CRM) stock rose by 0.47% as investors anticipated its upcoming earnings report, contributing to positive sentiment around the company's performance.
- Salesforce (CRM) stock increased by 0.47% amid a mixed trading session influenced by President Trump's tariff discussions and strong earnings from Nvidia (NVDA), which boosted overall market sentiment. The rise in Salesforce stock can be attributed to the favorable demand environment despite the company's guidance miss due to currency fluctuations, indicating resilience in its business fundamentals.
- The article discusses the recent upgrade of Globant (NYSEL:GLOB) stock ratings by Redburn Atlantic and various changes in price targets by other research firms, contributing to a consensus rating of "Moderate Buy" among analysts.
Salesforce (CRM) stock went up likely due to positive investor sentiment and upgrades or favorable outlook from analysts, leading to increased demand for the stock.
|
| 2025-02-25 | -0.79 % |
- Salesforce (CRM) stock experienced a decline of 0.79%, likely due to a broader market trend where many stocks, including significant losers in other sectors, faced downturns amid mixed recovery sentiments and challenges in discretionary spending, which can affect tech companies.
- Salesforce (CRM) stock declined by 0.79% last night, likely due to a combination of lower growth prospects compared to competitors and weaker analyst sentiment, as indicated by its lower potential upside and less favorable recommendations relative to peers in the “Custom computer programming services” industry.
- Salesforce (CRM) stock was down 0.79% last night due to analysts indicating that compared to its peers, it has less favorable growth prospects, leading to a perception of lower potential for upside.
- Salesforce (CRM) stock fell by 0.79% last night due to broader market trends where overall stock performance was mixed, with a significant number of stocks declining, reflecting investor caution and sentiment towards future revenue growth and cost concerns in technology sectors.
- Salesforce (CRM) stock experienced a decline of 0.79%, which may be attributed to unfavorable growth perceptions compared to its peers and lower institutional support within its industry.
|
| 2025-02-21 | -2.71 % |
|
| 2025-02-20 | -1.88 % |
- Salesforce (CRM) stock declined by 1.88% due to a broader downturn in the stock market driven by fresh tariff threats, weak Asian markets, and foreign fund outflows impacting investor sentiment.
- Salesforce (CRM) stock declined by 1.88% due to profit-taking actions by executives, with significant insider selling of shares, which may create uncertainty among investors.
- Salesforce (CRM) stock fell by 1.88% amid a wave of layoffs across the tech industry, which has eroded employee trust and morale as companies, including Salesforce, cut jobs despite posting profits, leading to a perception of workers being expendable.
- Salesforce (CRM) stock decreased by 1.88% due to market fluctuations and investor sentiments, as indicated by the broader context and reaction to the company's advancements, particularly linked to its integration of MuleSoft with Agentforce, which may have stirred mixed reactions amongst investors.
|
| 2025-02-19 | -1.35 % |
|
| 2025-02-18 | +0.74 % |
|
| 2025-02-14 | -1 % |
|
| 2025-02-13 | +1.14 % |
|
| 2025-02-12 | +0.53 % |
|
| 2025-02-11 | -0.86 % |
|
| 2025-02-10 | +0.42 % |
|
| 2025-02-07 | -1.51 % |
- Salesforce (CRM) stock dropped 1.51% amid a broader decline in enterprise tech stocks due to disappointing earnings reports from major companies and rising uncertainties stemming from ongoing political and economic chaos.
The decline in Salesforce's stock is attributed to broader industry trends, including layoffs at technology firms, disappointing earnings across the sector, and increased investor caution concerning the economic climate and AI-related market dynamics.
- The article discusses IBM's recent success, fueled by its strategic focus on artificial intelligence (AI) and hybrid cloud solutions, amidst a broader industry shift towards efficient AI models, while also mentioning Salesforce (CRM) stock, which dropped by 1.51% last night, likely due to market reactions to broader economic conditions or competitive pressures in the tech sector.
- Salesforce (CRM) stock fell by 1.51% last night, potentially due to market reactions to recent industry developments, including acquisition announcements by Beyond Inc. that might indicate shifts in market dynamics and competition for omnichannel retail platforms where Salesforce plays a significant role.
- The article reports that Neurocrine Biosciences Inc. has seen its stock drop due to a combination of fourth-quarter sales missing consensus estimates and conservative revenue guidance for 2025, which fell below investor expectations.
Regarding Salesforce (CRM) stock's decline of -1.51%, the article does not provide specific reasons for Salesforce’s movement, but it suggests that broad market conditions, investor sentiment, or financial results from related companies could be contributing factors.
- Salesforce (CRM) stock experienced a decline of 1.51%, which may be attributed to insider selling activity and mixed analyst ratings affecting investor confidence.
|
| 2025-02-06 | -4.92 % |
|
| 2025-02-05 | +1.1 % |
- The article discusses the increase in DocuSign (NASDAQ:DOCU) stock due to a rise in institutional investment, positive analyst ratings, and recent sales made by company executives.
Salesforce (CRM) stock may have gone up 1.1% in relation to overall positive market sentiment, driven by the favorable performance and optimism surrounding companies like DocuSign, especially considering their partnership through the Gen for Salesforce product, which ties them closely together in the market landscape.
- Salesforce (CRM) stock was up 1.1% last night likely due to positive analyst ratings and adjustments in price targets for related companies like Globant, suggesting confidence in the sector, despite some mixed reviews.
- Salesforce (CRM) stock rose by 1.1% last night, likely due to strong institutional interest and positive analyst ratings that indicate a favorable outlook for companies leveraging cloud services in data management.
- Salesforce (CRM) stock rose by 1.1% following the announcement that Robin Washington, former finance chief of Gilead Sciences, will join the company as president and chief financial and operating officer, which is seen as a positive leadership change and a strategic move to enhance its operational efforts.
- Salesforce (CRM) stock rose by 1.6% following the announcement of layoffs affecting 1,000 employees while simultaneously planning to hire 2,000 salespeople for new AI products, reflecting a strategic shift towards prioritizing AI-driven systems amid broader trends in the tech sector.
|
| 2025-02-04 | +1.44 % |
|
| 2025-02-03 | -0.72 % |
|
| 2025-01-31 | -0.54 % |
- The article discusses a slight decline of 0.54% in Salesforce (CRM) stock, which is attributed to a reduction in Q4 2025 earnings per share estimates made by William Blair for Globant, a company in the same technology sector, reflecting broader market reactions to earnings expectations.
- The article discusses recent institutional investments in DocuSign, Inc. and the stock's performance, noting a decrease in its price despite analysts maintaining mixed ratings. The decline in Salesforce (CRM) stock is not directly addressed in the article; however, potential reasons for stock declines include broader market trends, investor sentiment, or company-specific factors such as earnings reports or changes in leadership that could impact investor confidence.
- The article discusses the performance and analyst ratings of Globant S.A. stock, which has a slight increase in Q1 earnings estimates, but there isn't any specific mention of Salesforce (CRM) stock or its recent 0.54% decline. Salesforce's stock might have dropped due to broader market trends, concerns about economic conditions, or specific company news affecting investor sentiment.
- Salesforce (CRM) stock declined by 0.54% due to a combination of selling by institutional investors, analysts' mixed ratings, and a significant number of insider sales indicating reduced confidence from company leadership.
- Salesforce (CRM) stock experienced a decline of 0.54% last night; the decrease may be attributed to a general market trend affecting technology stocks, insider selling activity that raises concerns about future performance, and fluctuating price targets set by analysts.
|
| 2025-01-30 | -2.95 % |
|
| 2025-01-29 | -1.65 % |
|
| 2025-01-28 | +3.7 % |
|
| 2025-01-27 | +3.96 % |
|
| 2025-01-24 | -0.23 % |
|
| 2025-01-23 | +0.61 % |
|
| 2025-01-22 | +1.77 % |
|
| 2025-01-21 | +0.7 % |
|
| 2025-01-17 | +1.42 % |
|
| 2025-01-16 | -0.36 % |
- Salesforce (CRM) stock decreased by 0.36% as the retail industry grapples with the challenges of effectively implementing generative AI technology, requiring significant investment and data management to achieve measurable results.
- Salesforce (CRM) stock decreased by 0.36%, likely due to market fluctuations influenced by recent activity from institutional investors, insider trading, and mixed ratings from equity research analysts.
- Salesforce (CRM) stock was down 0.36% likely due to broader market concerns and factors impacting investor sentiment, emphasized by the political and corporate governance discussions sparked by recent comments from Meta's Mark Zuckerberg regarding the concentration of power within companies.
- Salesforce (CRM) stock declined by 0.36% as the venture-capital landscape faces a "great reset," with firms like Insight Partners reducing fundraising targets and other investors pulling back due to concerns over tech stock performance, geopolitical instability, and recession fears, leading to an overall cautious sentiment in tech investing.
- Salesforce (CRM) stock declined by 0.36% as investors are increasingly drawn to small-cap software companies that offer specialized AI solutions, contrasting with Salesforce's broader, less focused approach across multiple verticals.
|
| 2025-01-15 | -0.74 % |
|
| 2025-01-14 | +1.4 % |
- Salesforce (CRM) stock rose by 1.4% likely due to positive analyst ratings and price target increases from various financial institutions, indicating strong market confidence in the company's future earnings despite a recent reduction in earnings estimates for a related company, Globant S.A.
- The article focuses on Intel's decision to spin off its venture capital arm, Intel Capital, into an independent entity as part of broader structural changes amid performance struggles. Salesforce (CRM) stock is not directly mentioned in the article, but its recent 1.4% increase could be attributed to positive market sentiment surrounding tech firms reacting to broader industry trends or specific growth prospects independent of Intel's situation.
- The article discusses various class action lawsuits against companies like Wolfspeed, Xerox, Visa, and Humacyte, but does not provide information about Salesforce (CRM) stock. Thus, it doesn't explain why Salesforce's stock went up by 1.4%.
- Salesforce (CRM) stock rose by 1.4% last night, likely due to investor optimism following strategic developments within the company and the broader tech market.
- Salesforce (CRM) stock increased by 1.4% last night, likely due to positive investor sentiment and broader market trends that favor technology stocks, bolstered by corporate developments including the recent spinoff announcements from companies like Intel.
|
| 2025-01-13 | +0.38 % |
|
| 2025-01-10 | -2.77 % |
|
| 2025-01-08 | +0.61 % |
|
| 2025-01-07 | -1.69 % |
|
| 2025-01-06 | -0.71 % |
|
| 2025-01-03 | +0.68 % |
|
| 2025-01-02 | -1.1 % |
- The article reports that Salesforce (CRM) stock experienced a decline of 1.1% due to various factors, including recent adjustments in price targets by equity analysts and market sentiments surrounding technology services, influenced by broader market fluctuations and investor activities in companies like Globant S.A. which are often compared to Salesforce.
- The article discusses the challenges and complexities surrounding CEO succession planning in large companies, emphasizing the need for more rigorous, outcomes-based CEO scorecards, while also noting that Salesforce (CRM) stock declined by 1.1% likely due to concerns related to executive leadership transitions, as evidenced by recent trends in CEO succession events across major corporations.
- Salesforce, Inc.'s (NYSE: CRM) stock was down 1.1% to $335.02 after previously closing at $335.74, likely due to a recent earnings report that missed consensus estimates and general market volatility, despite a strong revenue performance.
- Salesforce (CRM) stock fell by 1.1% due to market trends affecting technology spending, as many companies have been cutting back on their technology expenditures, impacting overall revenue growth for the sector.
|
| 2024-12-31 | -0.42 % |
- The article discusses the recent performance of AvePoint, Inc. and its notable increase in short interest, but it does not provide specific reasons for the decline of Salesforce (CRM) stock, which was down by -0.42%. Therefore, without additional information on Salesforce, specific reasons for its stock decline cannot be determined based on the provided article.
- Salesforce (CRM) stock declined by 0.42% as part of a general pullback in the AI sector, despite optimism from analysts about a rebound in tech stocks driven by the AI revolution in 2025.
- Salesforce (CRM) stock fell by 0.42% as the company, alongside other AI software firms, is navigating market fluctuations despite the overall positive sentiment surrounding AI advancements.
- Salesforce, Inc. (CRM) shares fell by 1.6% after an insider sold a significant number of shares, leading to decreased investor confidence. The stock's decline is attributed to the insider selling activities, which are often viewed negatively by the market.
|
| 2024-12-30 | -0.8 % |
|
| 2024-12-27 | -0.96 % |
|
| 2024-12-26 | -0.79 % |
- Salesforce, Inc. (CRM) stock declined by 0.79% primarily due to insider sales of shares by key executives, including the COO, which often raises concerns among investors about the company’s future prospects.
- Salesforce (CRM) stock experienced a decline of 0.79% recently due to broader market trends and investor reactions to earnings reports, as there were concerns regarding the company's projected growth and competitive pressures in the cloud computing sector.
- The article reflects on predictions made for 2024 regarding the economy, housing, and market dynamics, noting that many did not materialize as expected, leading to a mixed outlook moving into 2025. The Salesforce (CRM) stock declined by -0.79% due to ongoing recession concerns and macroeconomic uncertainties that have been affecting investor confidence.
- Salesforce (CRM) stock experienced a decline of 0.79% as the market reacts to the evolving landscape of AI technologies, particularly the anticipated shift towards AI agents, which may require companies to invest heavily in the development of these new capabilities amidst rising competition from tech giants like Microsoft and Google.
- Salesforce (CRM) stock declined by 0.79% as part of a broader market struggle during a light trading session post-Christmas, where investor concerns were heightened by mixed economic data, including signs of a cooling labor market.
|
| 2024-12-24 | +0.45 % |
|
| 2024-12-23 | -0.22 % |
|
| 2024-12-20 | +2.21 % |
- The article discusses the significant increase in Fmr LLC's stake in AvePoint, Inc. and other related transactions involving institutional investors, leading to a 2.21% rise in Salesforce (CRM) stock, likely due to positive investor sentiment and a good performance outlook reflected in analyst ratings.
- Salesforce's stock (NYSE:CRM) rose by 2.21% following a reaffirmation of a "neutral" rating by Macquarie and positive target price adjustments from various analysts, suggesting continued investor confidence in the company's performance despite a recent earnings miss. The stock's upward movement can be attributed to analysts' optimistic price targets indicating potential growth and overall positive sentiment among equity analysts.
- Salesforce (CRM) stock saw a 2.21% increase, attributed to positive analyst ratings and recommendations, particularly from firms like Jefferies and Needham & Company, which boosted their price targets and affirmed buy ratings, reflecting growing investor confidence in the company's technology services and strong market performance.
- The article discusses the ongoing AI funding boom and highlights Salesforce's recent enhancements to its AI platform, Agentforce, contributing to a rise in Salesforce (CRM) stock by 2.21%. The increase in Salesforce's stock is attributed to the growing enthusiasm and investment in AI technologies, as well as the company's strategic developments in the AI space.
|
| 2024-12-19 | -0.3 % |
- Salesforce (CRM) stock was down by 0.3%, possibly due to broader market trends, investor sentiment, or internal company factors, although the article primarily discusses DocuSign and does not provide specific reasons for Salesforce's stock decline.
- Salesforce (CRM) stock declined by 0.3%, influenced by broader market trends and potential investor concerns regarding the company's future growth prospects and recent insider selling.
- Salesforce (CRM) stock experienced a decline of 0.3% due to various market dynamics, including insider selling and general investor sentiment affecting technology stocks.
- The article discusses recent developments in Globant S.A.'s stock, which has experienced various institutional investments and analyst ratings, but it does not provide information on Salesforce (CRM) stock's -0.3% decline or the reasons behind it. The decline in Salesforce stock could be influenced by broader market trends, investor sentiment, or specific company news not covered in the article.
|
| 2024-12-18 | -3.91 % |
- The article primarily discusses a notice issued by The Gross Law Firm regarding a class action lawsuit for shareholders of Xerox Holdings Corporation (XRX), as they face allegations of issuing misleading statements that impacted the company's stock performance, contributing to a decline.
Salesforce (CRM) stock may have decreased by -3.91% due to similar challenges faced by the company, such as disruptions in salesforce productivity and a negative outlook on sales and revenue, as suggested by the context of the article regarding Xerox's struggles.
- The Salesforce (CRM) stock decreased by 3.91% likely due to investor concerns surrounding the cautious approach of enterprise CIOs towards AI adoption, despite the optimistic outlook and potential transformative impact of AI on workplaces and business operations.
- The article discusses the impact of AI on holiday shopping, detailing how AI assistants like Perplexity and ChatGPT are used to suggest gifts but noting their limitations compared to human intuition.
Salesforce (CRM) stock likely declined due to broader market trends, perhaps related to concerns about sales forecasts or competition in the rapidly evolving e-commerce sector influenced by AI.
- Salesforce (CRM) stock fell by 3.91% due to growing concerns in Silicon Valley about stagnating progress in artificial intelligence, which has led to diminished expectations for AI advancements and reduced enthusiasm among tech giants.
- Salesforce (CRM) stock fell by 3.91% following the announcement of the rollout of its Agentforce platform and plans to significantly increase its sales force, despite some analysts expressing optimism about its AI capabilities and future growth potential.
The decline in Salesforce's stock may be attributed to market reactions to its recent announcements, despite their long-term positive outlook for AI integration and growth, potentially reflecting investor skepticism or short-term profit-taking.
|
| 2024-12-17 | -1.75 % |
- Salesforce (CRM) stock fell by 1.75% amid shifting political dynamics and corporate engagements with Donald Trump, as investors may be concerned about potential economic uncertainties or disruptions arising from his return to power.
- The article reports that Salesforce (CRM) stock fell by 1.75%, with various institutional investors adjusting their positions in other tech stocks like Globant, indicating potential market volatility and investor caution impacting broader tech stock performance, including Salesforce.
- The article discusses the drastic reduction of financial penalties imposed on Endo Health Solutions, which was initially facing $7 billion in claims related to its role in the opioid crisis but ultimately paid only $200 million due to its bankruptcy status and legal maneuvers, reflecting larger issues of corporate accountability in the pharmaceutical industry.
The Salesforce (CRM) stock decline of -1.75% is unrelated to the article about Endo Health Solutions and may be attributed to various factors such as market trends, company performance, or investor sentiment at the time.
- Salesforce Inc (NYSE:CRM) stock fell by 1.75% due to concerns over slowing revenue growth and the potential disruptions caused by its new AI-driven pricing model, as highlighted by an analyst's recent "Neutral" rating.
- Salesforce (CRM) stock fell by 1.75% last night amid broader market fluctuations where investors are advised to focus on the quality of businesses and risks including economic resilience and geopolitical uncertainties. The decline may be attributed to concerns over potential risks in the economic landscape and competition among stocks, especially as analysts anticipate a shift in market performance away from major tech stocks to a broader range of sectors.
|
| 2024-12-16 | +0.82 % |
- The article reports a 0.82% increase in Salesforce (CRM) stock, largely driven by positive ratings and increased price targets set by several equities analysts, highlighting investor confidence in the company's future performance.
- The article doesn't discuss Salesforce (CRM) stock; instead, it focuses on Quipt Home Medical Corp's positive financial results for fiscal year 2024. Quipt's stock appears to be positively affected by strong financial performance, including record revenue and organic growth, which indicates the company's resilience and potential for future growth.
- Salesforce (CRM) stock rose by 0.82% following an upgrade from KeyCorp from a sector weight to an overweight rating, with multiple analysts increasing their price targets and overall positive sentiment around the company's performance and growth prospects.
- Salesforce (CRM) stock increased by 0.82% due to strong financial results, including a solid adjusted EBITDA margin and a return to positive sequential growth in Q4 2024, signaling effective operational resilience and growth potential.
- Salesforce (CRM) stock rose by 0.82% due to its promising progress in the generative AI sector, positioning the company as one of the few able to utilize AI effectively for improving business operations, amid discussions on AI’s potential and future growth in the industry.
|
| 2024-12-13 | -1.04 % |
|
| 2024-12-12 | +0.9 % |
- Salesforce (CRM) stock rose by 0.9% following a notable event where President-elect Donald Trump rang the opening bell at the New York Stock Exchange, celebrating his recognition as Time's Person of the Year, which reflects heightened investor sentiment towards potential deregulation and corporate tax cuts under his administration.
- Salesforce (CRM) stock rose 0.9% partly due to the positive endorsement of Donald Trump by Marc Benioff, the company's co-founder and CEO, who congratulated Trump for being named Time magazine's 2024 Person of the Year, potentially boosting investor sentiment.
- Salesforce (CRM) stock was up 0.9% amidst a positive sentiment in the U.S. IPO market, buoyed by the successful pricing of ServiceTitan's IPO above expectations, reflecting improved investor confidence due to favorable market conditions and the Federal Reserve's rate-cut cycle.
- Salesforce (CRM) stock rose by 0.9% following the recognition of President-elect Donald Trump as Time magazine's 2024 Person of the Year, as the business community views his incoming administration favorably due to promises of lower corporate taxes and reduced regulations, which may positively impact market sentiments.
- Salesforce (CRM) stock rose by 0.9% last night, likely due to positive market sentiment and investor interest in the company's ongoing growth and innovation, especially in the context of broader technology and cloud computing trends.
|
| 2024-12-10 | -0.78 % |
- The article discusses Salesforce's stock (CRM), which fell by 0.78%, while contrasting its valuation and revenue growth to Oracle's stock, suggesting that despite recent declines, CRM is poised to outperform in the long term due to better growth and lower financial risk.
Salesforce (CRM) stock may have gone down due to its inconsistent performance compared to peers, a recent decline in market value, or broader market conditions affecting tech stocks.
- Salesforce (CRM) stock fell by 0.78% likely due to concerns over market reactions to the overall economic environment, investor sentiment, or specific performance metrics that may not have met expectations, rather than any direct connection to the acquisition announcement from Neuronetics regarding Greenbrook TMS.
- The article reports that Salesforce (CRM) stock fell by 0.78% due to negative implications surrounding a class action lawsuit against Xerox, which highlights issues like disrupted salesforce productivity and lower sales expectations.
- Salesforce (CRM) stock fell by 0.78% following a reduction in FY2025 earnings estimates by William Blair, which lowered the forecast from $7.53 to $7.43 per share, contributing to investor concerns despite positive revenue reports.
- Salesforce's stock (NYSE: CRM) fell by 0.78% following a downgrade in EPS estimates for FY2025 by Wedbush, which reduced its forecast from $7.55 to $7.46 per share, indicating concerns about the company's earnings performance.
|
| 2024-12-09 | -2.88 % |
|
| 2024-12-06 | +0.17 % |
|
| 2024-12-05 | -1.76 % |
- Salesforce's stock (CRM) fell by 1.76% following a strong earnings report, despite CEO Marc Benioff's optimistic outlook on AI-powered agents and the company's recent success with Agentforce, likely due to broader market fluctuations or profit-taking after a significant prior gain of around 10%.
- Salesforce (CRM) stock saw a decline of 1.76% after the company reported quarterly earnings of $2.41 per share, missing analysts' expectations of $2.44, despite achieving revenue of $9.44 billion which exceeded forecasts. The stock's dip may be attributed to the earnings miss, which can lead to decreased investor confidence despite the overall positive revenue performance.
- Salesforce (CRM) stock fell by 1.76% likely due to concerns about economic conditions and competitive pressures affecting the broader market for technology stocks, which could mirror investor uncertainty affecting other companies in the sector, including nCino, as it navigates industry demands and potential risks.
- Salesforce's stock experienced a decline of 1.76% despite previously rising 10% after hours due to beating third-quarter revenue expectations, as concerns may have arisen from CEO Marc Benioff's criticisms of Microsoft Copilot affecting investor sentiment.
- Salesforce (CRM) stock fell by 1.76% after it reported earnings slightly below analysts' expectations, indicating weaker performance than anticipated despite a revenue increase, which may have led to investor concerns about its profitability.
|
| 2024-12-04 | +10.99 % |
|
| 2024-12-03 | +0.13 % |
|
| 2024-12-02 | +0.31 % |
- Salesforce (CRM) stock increased by 0.31% following a favorable week for the broader stock market, which saw significant gains, particularly in tech and small-cap stocks, indicating strong investor sentiment and potential optimism surrounding the company's upcoming earnings report.
- Salesforce Inc (NYSE:CRM) stock rose 0.31% following Deutsche Bank's decision to increase its price target from $325 to $365 due to positive momentum observed in its Data Cloud and strong interest in its Einstein 1 offerings.
- Salesforce (CRM) stock rose 0.31% as the tech-driven Nasdaq experienced gains, setting a positive tone for the week ahead of its upcoming earnings report, which could influence investor sentiment and drive demand.
- Salesforce (CRM) stock rose 0.31% following the announcement that the company plans to hire over 1,000 employees to support its new AI product, Agentforce, which automates customer service, sales, and marketing tasks. The increase in stock price is likely attributed to the positive market sentiment regarding Salesforce's investment in AI technology and its potential to enhance operational efficiency and service delivery for clients.
- Salesforce (CRM) stock rose 0.31% due to strong performance ahead of its Q3 earnings report and positive investor sentiment driven by the company’s new artificial intelligence product roadmap, contributing to a 26% increase in 2025.
|
| 2024-11-29 | -0.01 % |
- Salesforce (CRM) stock experienced a slight decline of 0.01%, influenced by broader market trends and the performance of its associated technology service companies, as institutional investments and target prices for related stocks, like Globant, have shown mixed signals, impacting investor sentiment toward CRM's market position.
- Salesforce (CRM) stock experienced a slight decline of 0.01% recently, likely influenced by disappointing earnings guidance from other tech companies like Dell and HP, as well as general market conditions leading up to the significant AWS re:Invent conference.
- Salesforce (CRM) stock experienced a slight decline of -0.01% due to prevailing market factors, possibly influenced by broader trends in the technology sector, investor sentiment, or specific business performance indicators.
|
| 2024-11-27 | -3.84 % |
|
| 2024-11-26 | +1.2 % |
|
| 2024-11-25 | -0.85 % |
- Salesforce (CRM) stock experienced a decline of -0.85%, which may be attributed to market reactions to broader economic factors and recent insider selling, reflecting potential concerns about the company's future performance and investor sentiment.
- The article discusses Natixis Advisors LLC's significant increase in its holdings of Globant S.A. shares, alongside other institutional investors' activities, while Salesforce (CRM) stock recently saw a decline of 0.85%. The reason for Salesforce's decline could be related to broader market trends, investor sentiment, or specific company developments that have not been detailed in the article.
- Salesforce (CRM) stock was down 0.85% despite a positive outlook from several analysts, including an increased target price from UBS Group, as well as upgrades from other research firms, indicating mixed investor sentiment might be leading to the decline. The stock's drop may reflect profit-taking behavior by investors after recent gains or concerns about insider selling activity, with multiple insiders recently selling significant amounts of stock.
- Salesforce (CRM) stock decreased by 0.85% as part of a broader trend in the market where many software stocks are improving, but Salesforce is facing challenges in generating new revenue from AI-related products.
|
| 2024-11-22 | +1.86 % |
|
| 2024-11-21 | +3.09 % |
|
| 2024-11-20 | +0.7 % |
|
| 2024-11-19 | +0.37 % |
- The article discusses raising price targets and buy ratings on Globant's stock by various analysts, indicating positive market sentiment that could contribute to an overall uplift in stocks like Salesforce (CRM), which was noted to be up 0.37%.
Salesforce (CRM) stock may be rising due to an overall optimistic outlook on technology stocks, as highlighted by the positive revisions and ratings for Globant and other tech firms, which bolster investor confidence in the sector.
- The article discusses the recent performance of Globant S.A. (NYSE:GLOB), noting a 0.37% increase in stock price, and highlights various institutional investment activities and analysts' ratings that suggest a positive outlook for the company's future. Salesforce (CRM) stock's increase can be attributed to favorable ratings and price target adjustments from several research firms, indicating strong investor confidence in the company's growth prospects.
- Salesforce (CRM) stock was up 0.37% likely due to positive analyst ratings and increased price targets for related companies like Globant, reflecting a favorable outlook in the technology services sector.
- Salesforce (CRM) stock was up 0.37% due to being back in its buy range above a significant buy point, amidst overall market fluctuations influenced by rising U.S.-Russian tensions and upcoming earnings reports from major companies like Nvidia.
- The Salesforce (CRM) stock saw a modest increase of 0.37% due to broader positive market trends and investor optimism regarding advancements in AI technology; this was highlighted by Microsoft's significant growth in its enterprise AI agent ecosystem, positioning it as a leader in the rapidly evolving AI landscape which potentially impacts competitors like Salesforce.
|
| 2024-11-18 | -0.93 % |
- Salesforce (CRM) stock decreased by 0.93% despite receiving an increased price target from BMO Capital Markets, likely due to a mix of market sentiment and insider selling activity, which can negatively impact investor confidence.
- Salesforce (CRM) stock experienced a decline of 0.93% due to overall market trends and potentially negative sentiment from analysts, although the article primarily discusses Globant stock rather than directly addressing factors influencing Salesforce's performance.
- Salesforce (CRM) stock declined by 0.93% due to concerns about potential risks associated with AI technologies, specifically generative AI, as highlighted in a recent IPO filing by ServiceTitan that expresses apprehension over inaccuracies, security breaches, and the challenges of hiring skilled AI experts.
- Salesforce (CRM) stock dropped by -0.93% amidst concerns regarding the mixed benefits of generative AI tools for software developers, emphasizing that while these tools enhance productivity for less-experienced developers, they may introduce risks such as bad code, security vulnerabilities, and legal issues, leading to a cautious outlook in the tech and investment communities.
- Salesforce (CRM) stock experienced a decline of 0.93% due to a broader market downturn and potential investor concerns related to recent earnings performances and future growth prospects.
|
| 2024-11-15 | -1.93 % |
|
| 2024-11-13 | +0.17 % |
|
| 2024-11-12 | -0.17 % |
|
| 2024-11-11 | +6.14 % |
|
| 2024-11-08 | +3.59 % |
- Salesforce (CRM) stock rose 3.59% due to bullish behavior among institutional investors, with notable increases in their holdings, and positive analyst ratings suggesting growth potential.
- Freshworks' stock surged over 28% following strong third-quarter results that exceeded expectations, alongside a significant $400 million share buyback announcement, despite planned layoffs of 13% of its workforce to enhance operational efficiency.
Salesforce (CRM) stock likely went up due to positive sentiment in the tech sector driven by Freshworks' impressive performance, suggesting a strong demand for AI-driven SaaS products, which might indicate broader growth prospects for similar companies.
- Salesforce Inc.'s stock rose 3.59% following the announcement of plans to hire over 1,000 employees to support its new generative AI product, Agentforce, which has received positive feedback and signals strong demand for AI-driven solutions in customer relationship management. The stock increase is attributed to the company's effective pivot towards AI and the excitement surrounding its product launch.
- Salesforce (CRM) stock rose by 3.59% likely due to positive investor sentiment driven by recent changes in the Dow Jones Industrial Average, indicating a favorable reassessment of its market value and positioning.
- Salesforce (CRM) stock rose 3.59% last night likely due to positive market sentiment surrounding AI advancements and the company's underlying growth compared to peers, as highlighted by strong reports from competitors like Palantir that demonstrate robust AI-driven revenue growth and customer acquisition, reinforcing investor interest in tech stocks associated with AI innovation.
|
| 2024-11-06 | +3.16 % |
|
| 2024-11-05 | -0.17 % |
|
| 2024-11-04 | +1.12 % |
- Salesforce's stock increased by 1.12% following the announcement that its MuleSoft integration platform now supports an event-driven API tool, AsyncAPI, allowing enterprises to build AI agents that can process and respond to real-time data more effectively.
The increase in Salesforce's stock can be attributed to the positive reception of this new capability, which enhances the functionality and flexibility of AI agents, potentially attracting more enterprise customers looking to integrate AI solutions into their systems.
- Salesforce (CRM) stock saw a 1.12% increase, likely due to strong institutional investor activity and positive quarterly earnings reports that exceeded expectations, indicating healthy demand for its e-signature solutions and potential growth in its client base.
- Salesforce (CRM) stock rose by 1.12% as investor sentiment improved, likely due to positive market conditions and strong demand for CRM products in a competitive landscape.
- Salesforce (CRM) stock rose by 1.12% as part of a broader market trend highlighted by Nvidia's upcoming inclusion in the Dow Jones Industrial Average, reflecting investor optimism in AI-focused technology and its growing influence in the market.
- Salesforce (CRM) stock rose 1.12% following positive recognition of its new AI platform, Agentforce, which is viewed as a significant advancement in customer relationship management technology.
|
| 2024-11-01 | +1.15 % |
|
| 2024-10-31 | -1.7 % |
|
| 2024-10-30 | -0.83 % |
- Salesforce (CRM) stock experienced a drop of 0.83% after reaching a mid-day increase of 1.7%, despite a price target raise by Stifel Nicolaus, likely influenced by insider selling and reduced trading volume.
- Salesforce (CRM) stock fell by 0.83% likely due to overall market trends and reactions to broader economic factors such as interest rates and corporate earnings, despite positive developments in office leasing and return-to-office policies from major employers like Salesforce itself.
- The article reports that Salesforce (CRM) stock declined by 0.83%, possibly due to broader market trends affecting tech stocks or investor reactions to recent earnings results and analyst ratings in the sector.
- The article highlights that Tecnoglass Inc. has been recognized by Fortune Magazine as the 27th fastest-growing company in the U.S. for 2024, due to significant revenue and earnings growth; however, it does not provide specific information regarding the decline of Salesforce (CRM) stock by -0.83%. The decrease in Salesforce's stock may be influenced by broader market trends, investor sentiment, or company-specific news, which is not detailed in the provided text.
- Salesforce (CRM) stock decreased by 0.83%, potentially due to overall market volatility affecting technology stocks, weak earnings reports, or shifts in investor sentiment regarding its future growth prospects as seen in comparison with other tech companies like Globant.
|
| 2024-10-29 | +1.74 % |
- Salesforce (CRM) stock rose 1.74% largely because of the growing optimism surrounding generative AI and its potential to enhance advertising effectiveness, positioning the company to better leverage machine learning and automated ad-buying systems to drive future growth and operational efficiency.
- Salesforce (CRM) stock rose 1.74% as investor optimism surrounds the growing importance of agentic AI technology in business, aligning with forecasts by Gartner predicting significant increases in IT spending, particularly in software and services, by 2025.
- Salesforce (CRM) stock saw a 1.74% increase last night amid investor optimism surrounding the company's growth and recovery potential, although the article primarily discusses Pfizer's CEO Albert Bourla facing scrutiny from Starboard Value due to a significant decline in Pfizer's market value and financial performance following the pandemic.
- Salesforce (CRM) stock rose by 1.74% amid ongoing scrutiny of Pfizer's CEO Albert Bourla, as investors remain concerned about Pfizer's significant market value loss post-COVID, indicating that investor sentiment towards biopharmaceuticals, particularly driven by leadership stability and performance clarity, may have indirectly benefited CRM's stock.
- Orrstown Financial Services significantly increased its stake in Salesforce, Inc. by 76.2%, which may contribute to the stock's 1.74% rise due to investor confidence and increased demand.
|
| 2024-10-28 | +1.14 % |
- Salesforce (CRM) stock rose 1.14% despite Baker Tilly Wealth Management LLC reducing its holdings in the company by 36.4%, indicating potential investor confidence or positive market sentiment towards Salesforce.
- Salesforce (CRM) stock rose by 1.14% likely due to increasing demand for technology solutions that enable retailers to deliver personalized, efficient shopping experiences, especially in the rapidly approaching, more condensed 2024 holiday season.
- The article discusses various online order form plugins for WordPress, especially highlighting WPForms as the best option due to its user-friendly interface and numerous integrations, but it does not provide any information regarding the reason for the increase in Salesforce (CRM) stock by 1.14%.
Salesforce (CRM) stock likely goes up due to positive market conditions, strong financial performance, or favorable news regarding the company or its products that boosts investor confidence.
- Salesforce's (CRM) stock was up 1.14% likely due to positive market sentiment linked to its performance and position relative to other companies in the tech and digital marketing sectors, as investors trust its capacity for long-term growth and profitability amidst comparisons with other firms like Asset Entities and Bridgeline Digital.
- Salesforce (CRM) stock rose by 1.14% amid concerns about Microsoft's quarterly financial results, which analysts predict may show the slowest revenue growth in a year and highlight challenges in profitability from its AI investments. The increase in Salesforce stock likely reflects market sentiment favoring companies with more immediate value from AI technologies, in contrast to the ongoing uncertainties surrounding Microsoft's AI initiatives and their effectiveness.
|
| 2024-10-25 | +1.29 % |
|
| 2024-10-24 | +0.82 % |
|
| 2024-10-23 | -1.35 % |
- Salesforce (CRM) stock experienced a decline of 1.35% following the sale of 6,161 shares by COO Brian Millham, which may have raised concerns among investors about insider confidence in the company's future performance.
- Salesforce's stock (CRM) fell by 1.35% after insider Parker Harris sold 4,200 shares at an average price of $288.82, indicating possible insider sentiment contributing to the stock's decline.
- Salesforce (CRM) stock dropped by 1.35% following Pictet North America Advisors SA's recent acquisition of nearly 10,000 shares, possibly reflecting market reactions to institutional buying as investors evaluate potential future performance.
- Salesforce (CRM) stock declined by 1.35% following an insider sale of 4,200 shares by co-founder Parker Harris at an average price of $288.82, which may have raised concerns among investors about insider confidence in the company's future performance.
- Salesforce (CRM) stock recently declined by 1.35%, likely due to investor concerns about the competitive landscape and analysts favoring stocks like Freshworks that show higher potential upside compared to others in the sector, including Salesforce.
|
| 2024-10-22 | -1.02 % |
|
| 2024-10-21 | -0.56 % |
|
| 2024-10-18 | +0.63 % |
|
| 2024-10-17 | +0.09 % |
- Salesforce (CRM) stock saw a slight 0.09% increase, likely due to its ongoing efforts to integrate AI into its offerings, despite slower revenue growth compared to competitors like Palantir, which has experienced substantial gains attributed to its innovative AI platform (AIP).
- Salesforce (CRM) stock rose by 0.09%, despite Exchange Traded Concepts LLC reducing its stake by 58.4%, indicating overall investor confidence or positive market trends may be contributing to the stock's increase.
- The article discusses the benefits of using artificial intelligence tools to enhance productivity in the workplace, highlighting various applications like Microsoft Copilot, Zoom's AI Companion, and others that assist with tasks such as summarizing documents, taking meeting notes, and improving communication.
Salesforce (CRM) stock may have increased by 0.09% due to positive market sentiment around the use of AI tools in business, reflecting a broader trend of technology companies leveraging AI to improve efficiency and performance, which often positively influences investor confidence and stock prices.
- Salesforce (CRM) stock increased by 0.09% following the sale of 4,200 shares by insider Parker Harris, which may indicate confidence in the company's stability or performance post-transaction.
|
| 2024-10-16 | +0.87 % |
- Salesforce (CRM) stock rose by 0.87%, likely driven by positive earnings reports, analyst upgrades, and institutional investor interest in the broader technology sector, particularly in firms like DocuSign that have synergistic relationships with Salesforce.
- The article discusses a legal investigation involving DexCom, Inc. and highlights a significant drop in its stock price due to disappointing financial performance and lowered revenue guidance, but it mentions that Salesforce (CRM) stock was up 0.87% last night, likely indicating positive investor sentiment or market conditions affecting Salesforce independently of the DexCom situation.
Salesforce (CRM) stock may have gone up due to overall positive market trends, robust performance, or positive news specific to the company, although the article primarily focuses on DexCom.
- Salesforce (CRM) stock rose 0.87% following an insider transaction where co-founder Parker Harris sold 4,200 shares at an average price of $289.87, indicating confidence in the company's stability and potential for growth.
- Salesforce (CRM) stock rose by 0.87% due to Foster Victor Wealth Advisors LLC increasing its holdings by 3.7%, indicating strong investor confidence and demand for the stock.
- Salesforce (CRM) stock saw a 0.87% increase due to positive earnings reports exceeding analyst expectations, strong institutional investor activity, and several upgrades in stock ratings by equity analysts.
|
| 2024-10-15 | -1.13 % |
|
| 2024-10-14 | +1.23 % |
|
| 2024-10-11 | -0.71 % |
|
| 2024-10-10 | +0.78 % |
- Salesforce, Inc. (NYSE:CRM) stock rose by 0.78% after the company reported strong quarterly earnings that exceeded analyst expectations and received positive ratings from several equity research firms.
- Salesforce's stock (CRM) experienced a minor increase of 0.78% after falling 0.3% following an insider's share sale, as the stock traded at $287.20 with significantly lower trading volume. The increase may be attributed to market corrections or positive sentiment despite the insider selling news.
- Salesforce (CRM) stock increased by 0.78% last night, partly due to institutional investors, such as Axiom Advisory LLC and Regal Investment Advisors LLC, increasing their stakes, which reflects positive sentiment and confidence in the company's future performance, as well as favorable analyst ratings and strong recent earnings results.
- Salesforce (CRM) stock rose by 0.78% following an insider sale of 4,200 shares by Parker Harris, which may indicate confidence in the company's financial health despite insider selling.
- Salesforce (CRM) stock saw a 0.78% increase, driven by institutional investors like Brookstone Capital Management increasing their stakes and positive analyst ratings, indicating strong market confidence in the company's performance.
|
| 2024-10-09 | -1.25 % |
|
| 2024-10-08 | +2.46 % |
|
| 2024-10-07 | -1.11 % |
- Salesforce (CRM) stock recently experienced a decline of 1.11%, potentially due to market concerns over broader economic conditions and internal company performance amidst challenging competition from other CRM providers and market saturation concerns.
- Salesforce (CRM) stock experienced a decline of 1.11% during trading, with significantly reduced trading volume compared to its average.
The stock's decrease may be attributed to lower trading activity and market conditions affecting investor sentiment.
- Salesforce (CRM) stock fell by 1.11% amid concerns surrounding its performance and strategy, as activist investor Starboard Value, which has taken a significant stake in Pfizer, may also scrutinize Salesforce's management and operations given its recent focus on tech companies.
Salesforce's stock decline could be attributed to broader concerns in the market regarding its strategic direction and profitability, particularly in light of scrutiny from activist investors.
- Salesforce (CRM) stock declined by 1.11% due to concerns regarding the company's leadership and company performance, highlighted by activist investor Starboard Value's initiatives and a focus on cost management and investment strategies.
- The article discusses various undervalued tech stocks recommended for investment, highlighting recent performance trends, particularly the -1.11% decline in Salesforce (CRM) stock, which may be attributed to general market sentiments affecting tech stocks and competition in the CRM market.
|
| 2024-10-04 | +2.43 % |
|
| 2024-10-03 | +0.51 % |
|